EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salicylaldehyde Benzoylhydrazone Protects Against Ferroptosis in Models of Neurotoxicity and Behavioural Dysfunction, In Vitro and In Vivo

Niamh C Clarke, Ellen McCabe, Lasse D Jensen, Bernadette S Creaven, Derek A Costello

Journal of Molecular Neuroscience · 14.06.2025 · 75 (2)

DOI: 10.1007/s12031-025-02371-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 14.06.2025. Verfasst von Niamh C Clarke und 4 weiteren Autor:innen. Beteiligte Einrichtung: UCD School of Biomolecular & Biomedical Science, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Ferroptosis, Hydrazones, Aldehydes, Neuroprotective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Ireland/Taighde Éireann, European Union's Horizon 2020 Marie Skłodowska-Curie Actions, University College Dublin, STEM Challenge Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal dyshomeostasis in the brain is a key feature of many neuropathologies, including hypoxic and traumatic injury and chronic conditions such as Alzheimer’s and Parkinson’s disease. Ferroptosis is a form of cell death driven by the intracellular accumulation of iron. This is primarily characterised by a loss in endogenous antioxidant capacity and uncontrolled lipid peroxidation. Ferroptosis has been reported to underlie the pathology associated with several neurological and neurodegenerative conditions and has, therefore, become an attractive target for therapeutic intervention. Salicylaldehyde benzoylhydrazone (SBH) is a specialised hydrazone agent, known for its antibacterial and anticancer properties. It has robust metal-chelating capacity, with a particular affinity for complexing with iron and copper. The current study sought to investigate the potential of SBH to act as an anti-ferroptotic agent and to alleviate the neurotoxic and dysfunctional consequences of iron overload. We demonstrate that SBH can alleviate the death of HT22 hippocampal neurons, induced by exposure to the iron donor, ferric ammonium citrate (FAC). This was accompanied by a reduction in intracellular iron and lipid peroxidation, and alleviation of hallmark changes in gene expression indicative of ferroptosis. Using FAC-incubated zebrafish larvae as an in vivo model of iron overload, we reveal that SBH can reduce the mortality and toxicity associated with FAC exposure. Moreover, we report a FAC-mediated dysfunction in intrinsic sensorimotor reflex behaviour, which is restored by SBH. Taken together, our findings highlight SBH as an anti-ferroptotic agent and support its further investigation as a potential neurotherapeutic for conditions associated with iron dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHydrazonesAldehydesNeuroprotective AgentsAnimalsZebrafishMiceNeuronsCell LineHippocampusLipid PeroxidationIron

Stichwörter der Autor:innen

Ferric ammonium citrateHT22 cellsIron overloadLipid peroxidationSchiff baseZebrafish larvae

Substanzen

HydrazonesAldehydesNeuroprotective AgentsIronsalicylaldehyde

Autor:innen und Institutionen

  • UCD School of Biomolecular & Biomedical Science, University College Dublin, Dublin, Ireland.
  • UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • BioReperia AB, Linköping, Sweden.
  • School of Chemical and BioPharmaceutical Science, Technological University Dublin, Dublin, Ireland.
  • UCD School of Biomolecular & Biomedical Science, University College Dublin, Dublin, Ireland. derek.costello@ucd.ie.

Förderung

  • Research Ireland/Taighde Éireann
  • European Union's Horizon 2020 Marie Skłodowska-Curie Actions
  • University College Dublin, STEM Challenge Fund
  • European Union’s Horizon 2020 Marie Skłodowska-Curie Actions
  • University College Dublin

Zitieren

APA

Clarke, N. C., McCabe, E., Jensen, L. D., Creaven, B. S., & Costello, D. A. (2025). Salicylaldehyde Benzoylhydrazone Protects Against Ferroptosis in Models of Neurotoxicity and Behavioural Dysfunction, In Vitro and In Vivo. Journal of Molecular Neuroscience, 75(2). https://doi.org/10.1007/s12031-025-02371-2

Vancouver

Clarke NC, McCabe E, Jensen LD, Creaven BS, Costello DA. Salicylaldehyde Benzoylhydrazone Protects Against Ferroptosis in Models of Neurotoxicity and Behavioural Dysfunction, In Vitro and In Vivo. Journal of Molecular Neuroscience. 2025;75(2). doi:10.1007/s12031-025-02371-2

BibTeX
@article{Clarke2025,
  author = {Clarke, Niamh C and McCabe, Ellen and Jensen, Lasse D and Creaven, Bernadette S and Costello, Derek A},
  title = {Salicylaldehyde Benzoylhydrazone Protects Against Ferroptosis in Models of Neurotoxicity and Behavioural Dysfunction, In Vitro and In Vivo},
  journal = {Journal of Molecular Neuroscience},
  year = {2025},
  volume = {75},
  number = {2},
  doi = {10.1007/s12031-025-02371-2}
}
Kostenlos starten →